Gruis N - Search Results

1

Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.

Demenais F, Mohamdi H, Chaudru V, Goldstein AM, Newton Bishop JA, Bishop DT, Kanetsky PA, Hayward NK, Gillanders E, Elder DE, Avril MF, Azizi E, van Belle P, Bergman W, Bianchi-Scarrà G, Bressac-de Paillerets B, Calista D, Carrera C, Hansson J, Harland M, Hogg D, Höiom V, Holland EA, Ingvar C, Landi MT, Lang JM, Mackie RM, Mann GJ, Ming ME, Njauw CJ, Olsson H, Palmer J, Pastorino L, Puig S, Randerson-Moor J, Stark M, Tsao H, Tucker MA, van der Velden P, Yang XR, Gruis N; Melanoma Genetics Consortium. Demenais F, et al. Among authors: gruis n. J Natl Cancer Inst. 2010 Oct 20;102(20):1568-83. doi: 10.1093/jnci/djq363. Epub 2010 Sep 28. J Natl Cancer Inst. 2010. PMID: 20876876 Free PMC article.

2

The Dutch FAMMM family material: clinical and genetic data.

Bergman W, Gruis NA, Frants RR. Bergman W, et al. Among authors: gruis na. Cytogenet Cell Genet. 1992;59(2-3):161-4. doi: 10.1159/000133232. Cytogenet Cell Genet. 1992. PMID: 1737487 No abstract available.

3

Locus for susceptibility to melanoma on chromosome 1p.

Gruis NA, Bergman W, Frants RR. Gruis NA, et al. N Engl J Med. 1990 Mar 22;322(12):853-4. doi: 10.1056/nejm199003223221217. N Engl J Med. 1990. PMID: 2308622 No abstract available.

4

CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome families.

Gruis NA, Sandkuijl LA, van der Velden PA, Bergman W, Frants RR. Gruis NA, et al. Melanoma Res. 1995 Jun;5(3):169-77. doi: 10.1097/00008390-199506000-00005. Melanoma Res. 1995. PMID: 7640518

5

Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds.

Gruis NA, van der Velden PA, Sandkuijl LA, Prins DE, Weaver-Feldhaus J, Kamb A, Bergman W, Frants RR. Gruis NA, et al. Nat Genet. 1995 Jul;10(3):351-3. doi: 10.1038/ng0795-351. Nat Genet. 1995. PMID: 7670475

6

Genetics of seven Dutch familial atypical multiple mole-melanoma syndrome families: a review of linkage results including chromosomes 1 and 9.

Bergman W, Gruis NA, Sandkuijl LA, Frants RR. Bergman W, et al. Among authors: gruis na. J Invest Dermatol. 1994 Nov;103(5 Suppl):122S-125S. doi: 10.1111/1523-1747.ep12399430. J Invest Dermatol. 1994. PMID: 7963673 Free article.

7

Familial melanoma and pancreatic cancer.

Bergman W, Gruis N. Bergman W, et al. Among authors: gruis n. N Engl J Med. 1996 Feb 15;334(7):471-2. N Engl J Med. 1996. PMID: 8552160 No abstract available.

8

Affected members of melanoma-prone families with linkage to 9p21 but lacking mutations in CDKN2A do not harbor mutations in the coding regions of either CDKN2B or p19ARF.

Liu L, Goldstein AM, Tucker MA, Brill H, Gruis NA, Hogg D, Lassam NJ. Liu L, et al. Among authors: gruis na. Genes Chromosomes Cancer. 1997 May;19(1):52-4. Genes Chromosomes Cancer. 1997. PMID: 9135995

9

Germline mutations of the CDKN2 gene in UK melanoma families.

Harland M, Meloni R, Gruis N, Pinney E, Brookes S, Spurr NK, Frischauf AM, Bataille V, Peters G, Cuzick J, Selby P, Bishop DT, Bishop JN. Harland M, et al. Among authors: gruis n. Hum Mol Genet. 1997 Nov;6(12):2061-7. doi: 10.1093/hmg/6.12.2061. Hum Mol Genet. 1997. PMID: 9328469

10

Excess cancer mortality in six Dutch pedigrees with the familial atypical multiple mole-melanoma syndrome from 1830 to 1994.

Hille ET, van Duijn E, Gruis NA, Rosendaal FR, Bergman W, Vandenbroucke JP. Hille ET, et al. Among authors: gruis na. J Invest Dermatol. 1998 May;110(5):788-92. doi: 10.1046/j.1523-1747.1998.00185.x. J Invest Dermatol. 1998. PMID: 9579547 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

160 results

Search Page